A clinical profile of combination therapy comprising gemcitabine plus a platinum anti-cancer drug as second-line chemotherapy for advanced urothelial cancer: findings arising from the Japanese medical insurance limitations on gemcitabine use

Bibliographic Information

Other Title
  • A clinical profile of combination therapy comprising gemcitabine plus a platinum anti cancer drug as second line chemotherapy for advanced urothelial cancer findings arising from the Japanese medical insurance limitations on gemcitabine use
  • 進行性尿路上皮癌に対するセカンドライン療法としてのゲムシタビンとプラチナ系抗癌剤併用療法の臨床的検討--本邦でのゲムシタビン保険使用制限下での知見

Search this article

Journal

References(22)*help

See more

Details 詳細情報について

Report a problem

Back to top